Bay City Capital LLC
Director, 10% owner at MDGL; Other at NVRO; 10% owner at Epizyme, Inc.
- Sold, on record
- $124M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jun 11, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- MDGLMADRIGAL PHARMACEUTICALS, INC.Director, 10% owner
- NVRONEVRO CORPOther
- Epizyme, Inc.10% owner
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Epizyme, Inc.566,666 shares
- NVRO491,835 shares
- MDGL280,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Epizyme, Inc.Plan not statedAug 25, 2014 2014
Sold 366,666 shares at $33.98 ($12.5M)
Bay City Capital LLC, 10% owner
Sold 11.5% of holdings ($108M position)2.8M shares leftFirst sale on recordFiling
- 2 Form 4 sale Epizyme, Inc.Plan not statedAug 26, 2014 +1 day
Sold 200,000 shares at $35.14 ($7M)
Bay City Capital LLC, 10% owner
Sold 6.6% of holdings ($106M position)2.8M shares leftFiling
- 3 Form 4 sale NVROUnusualJun 8, 2015 +286 days
Sold 491,835 shares at $47.94 ($23.6M)
Bay City Capital LLC, Other
Sold 93.1% of holdings ($25.3M position)36,403 shares leftFirst sale on recordFiling
- 4 Form 4 sale MDGLUnusualJun 11, 2018 +1099 days
Sold 280,000 shares at $287.46 ($80.5M)
Bay City Capital LLC, Director, 10% owner
Sold 71.2% of holdings ($113M position)113,472 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2018 | Jun 12, 2018 | MDGL | Director, 10% owner | Form 4 sale | 280,000 | $80.5M | 71.2% | Unusual | SEC |
| Jun 8, 2015 | Jun 17, 2015 | NVRO | Other | Form 4 sale | 491,835 | $23.6M | 93.1% | Unusual | SEC |
| Aug 26, 2014 | Aug 28, 2014 | Epizyme, Inc. | 10% owner | Form 4 sale | 200,000 | $7M | 6.6% | Plan not stated | SEC |
| Aug 25, 2014 | Aug 25, 2014 | Epizyme, Inc. | 10% owner | Form 4 sale | 366,666 | $12.5M | 11.5% | Plan not stated | SEC |